Ann Arbor, MI, United States of America

Lizhong Wang


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Inventor Lizhong Wang

Introduction

Lizhong Wang is a prominent inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. His work focuses on the role of FOXP3 in tumor suppression, which has the potential to advance therapeutic strategies for cancer patients.

Latest Patents

Lizhong Wang holds a patent for "Materials and methods for FOXP3 tumor suppression." This patent outlines methods for treating cancer by administering a FOXP3 protein, a nucleic acid encoding a FOXP3 protein, or an inducing compound that promotes FOXP3 protein expression. The patent also describes techniques for altering the phenotype of cancer cells, inhibiting their growth, and inducing apoptosis. Additionally, diagnostic methods are provided to compare FOXP3 protein or gene expression in test samples against normal or prior samples. The patent includes a method for screening test compounds for anti-cancer activity by measuring FOXP3 expression.

Career Highlights

Lizhong Wang is affiliated with the University of Michigan, where he conducts his research and develops innovative cancer treatment methods. His work has garnered attention for its potential impact on cancer therapies and patient outcomes.

Collaborations

Some of his notable coworkers include Yang Liu and Pan Zheng, who contribute to the research efforts at the University of Michigan.

Conclusion

Lizhong Wang's innovative work in cancer treatment through the exploration of FOXP3 tumor suppression represents a significant advancement in the field. His patented methods and ongoing research hold promise for improving therapeutic options for cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…